BiomX
PHGE
10 hedge funds and large institutions have $2.62M invested in BiomX in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
11% more funds holding
Funds holding: 9 → 10 (+1)
0% less ownership
Funds ownership: 0.09% → 0.09% (-0%)
5% less capital invested
Capital invested by funds: $2.77M → $2.62M (-$151K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.56K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$74 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$51.6K |
| 2 |
Renaissance Technologies
New York
|
-$19.9K |
| 3 |
VF
Virtu Financial
New York
|
-$19K |
| 4 |
Millennium Management
New York
|
-$8.76K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $1.6M | – | – | – |
|
|
JJ
2
Johnson & Johnson
New Brunswick,
New Jersey
| $751K | – | – | – |
|
|
MI
3
MMCAP International
Grand Cayman,
Cayman Islands
| $180K | -$51.6K | -695 | -20% |
|
|
4
Renaissance Technologies
New York
| $51K | -$19.9K | -268 | -26% |
|
|
BCM
5
Bridgeway Capital Management
Houston,
Texas
| $17.4K | – | – | – |
|
|
6
Millennium Management
New York
| $8.22K | -$8.76K | -118 | -49% |
|
7
Walleye Capital
New York
| $7.41K | – | – | – |
|
8
Walleye Trading
New York
| $3.67K | – | – | – |
|
|
9
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1.41K | +$1.56K | +21 | New |
|
|
10
UBS Group
Zurich,
Switzerland
| $37 | +$74 | +1 | New |
|
|
VF
11
Virtu Financial
New York
| – | -$19K | -284 | Closed |
|
PHGE Hedge Fund Activity: Q3 2023 in Review
10 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q3 2023, worth a combined $2.62M — down 5.4% from $2.77M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PHGE positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was PNC Financial Services Group, opening a new position worth an estimated $1.56K. The largest seller was MMCAP International, cutting an estimated $51.6K.
- 10 institutional investors held BiomX (PHGE) as of Q3 2023, up from 9 in Q2 2023.
- Funds reported $2.62M of BiomX stock for Q3 2023, down 5.4% quarter-over-quarter.
- 2 funds opened new BiomX positions in Q3 2023 and 1 closed out, a net change of +1 holder.
- The largest BiomX buyer in Q3 2023 was PNC Financial Services Group, an estimated $1.56K added.
- The largest BiomX seller in Q3 2023 was MMCAP International, an estimated $51.6K sold.
Based on aggregated 13F filings for Q3 2023.